CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Panacea Biotec Ltd Company Snapshot
Business Description:
Panacea Biotec Ltd operates in the Biological products exc. diagnostic sector. Panacea Biotec Limited is a biotechnology Company. The Company operates in three segments: Vaccines, Formulations, and Research and Development Activities. The Company vaccines portfolio included Pediatric combination vaccines Easyfive (DTwP-HepB-Hib) & Easyfour (DTwP-Hib), PolProtec (enhanced Injectable Polio Vaccine) and PrimOpol (Trivalent Oral Poliomyelitis Vaccine). The Company's diabetes and cardiac care brands include Glizid M, Glizid 40 milligrams, Glizid 80 milligrams, Glizid MR 30 milligrams and Glizid MR 60 milligrams. Its pain management brands include Nimulid MD, Nimulid 100 milligrams, Nimulid MR, Nimulid SP, Kondro OD, Vacosteo and Willgo. Its tuberculosis management and gastro-intestinal bands include Myser and Livoluk. Its subsidiaries include Best On Health Limited (BOH), Radicura & Co. Limited, Panacea Hospitality Services Pvt. Ltd. and Panacea Educational Institute Pvt. Ltd. In our complete report available for purchase the company is compared to: Savita Oil Technologies Limited, Atul Ltd and Tamilnadu Petroproducts Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Panacea Biotec Ltd
  Stock Performance Chart for Panacea Biotec Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (2/10/2012): 88.70
(Figures in Indian Rupees)
1 Week 1.8%   13 Weeks 4.4%  
4 Weeks -12.9%   52 Weeks -50.5%  
 
Panacea Biotec Ltd Key Data:
  Ticker: 531349 Country: INDIA
  Exchanges: BOM Major Industry: Chemicals
    Sub Industry: Miscellaneous Chemicals
  2011 Sales 11,434,200,000
(Year Ending Jan 2012).		 Employees: 3,600
  Currency: Indian Rupees Market Cap: 5,432,941,170
  Fiscal Yr Ends: March Shares Outstanding: 61,250,746
  Share Type: Ordinary Closely Held Shares: 45,886,281
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.